{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:33:42Z","timestamp":1787067222263,"version":"build-2736575974"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T00:00:00Z","timestamp":1624579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>\n                    Autosomal recessive cerebellar ataxias (ARCAs) form an ultrarare yet expanding group of neurodegenerative multisystemic diseases affecting the cerebellum and other neurological or non-neurological systems. With the advent of targeted therapies for ARCAs, disease registries have become a precious source of real-world quantitative and qualitative data complementing knowledge from preclinical studies and clinical trials. Here, we review the\n                    <jats:italic>ARCA Registry<\/jats:italic>\n                    , a global collaborative multicenter platform (&amp;gt;15 countries, &amp;gt;30 sites) with the overarching goal to advance trial readiness in ARCAs. It presents a good clinical practice (GCP)- and general data protection regulation (GDPR)-compliant professional-reported registry for multicenter web-based capture of cross-center standardized longitudinal data. Modular electronic case report forms (eCRFs) with core, extended, and optional datasets allow data capture tailored to the participating site's variable interests and resources. The eCRFs cover all key data elements required by regulatory authorities [European Medicines Agency (EMA)] and the European Rare Disease (ERD) platform. They capture genotype, phenotype, and progression and include demographic data, biomarkers, comorbidity, medication, magnetic resonance imaging (MRI), and longitudinal clinician- or patient-reported ratings of ataxia severity, non-ataxia features, disease stage, activities of daily living, and (mental) health status. Moreover, they are aligned to major autosomal-dominant spinocerebellar ataxia (SCA) and sporadic ataxia (SPORTAX) registries in the field, thus allowing for joint and comparative analyses not only across ARCAs but also with SCAs and sporadic ataxias. The registry is at the core of a systematic multi-component ARCA database cluster with a linked biobank and an evolving study database for digital outcome measures. Currently, the registry contains more than 800 patients with almost 1,500 visits representing all ages and disease stages; 65% of patients with established genetic diagnoses capture all the main ARCA genes, and 35% with unsolved diagnoses are targets for advanced next-generation sequencing. The ARCA Registry serves as the backbone of many major European and transatlantic consortia, such as PREPARE, PROSPAX, and the Ataxia Global Initiative, with additional data input from SPORTAX. It has thus become the largest global trial-readiness registry in the ARCA field.\n                  <\/jats:p>","DOI":"10.3389\/fneur.2021.677551","type":"journal-article","created":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T02:40:45Z","timestamp":1624588845000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":31,"title":["The ARCA Registry: A Collaborative Global Platform for Advancing Trial Readiness in Autosomal Recessive Cerebellar Ataxias"],"prefix":"10.3389","volume":"12","author":[{"given":"Andreas","family":"Trasch\u00fctz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selina","family":"Reich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid D.","family":"Adarmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Anheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud Reza","family":"Ashrafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Baets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Nazli","family":"Basak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Bertini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Brais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Gagnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janina","family":"Gburek-Augustat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasmet A.","family":"Hanagasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Heinzmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Horvath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"de Jonghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Kamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Klivenyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Klopstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Minnerop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"M\u00fcnchau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Renaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard H.","family":"Roxburgh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo M.","family":"Santorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Schirinzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah A.","family":"Sival","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar","family":"Timmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Vielhaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wallner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart P.","family":"van de Warrenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginevra","family":"Zanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Zuchner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Klockgether","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Sch\u00fcle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludger","family":"Sch\u00f6ls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"PREPARE Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthis","family":"Synofzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,6,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/B978-0-444-64189-2.00005-6","article-title":"Recessive ataxias","volume":"155","author":"Synofzik","year":"2018","journal-title":"Handb Clin Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.neuron.2019.01.049","article-title":"Autosomal recessive cerebellar ataxias: paving the way toward targeted molecular therapies","volume":"101","author":"Synofzik","year":"2019","journal-title":"Neuron."},{"key":"B3","unstructured":"European Medical Agency. Guideline on Registry-Based Studies"},{"key":"B4","unstructured":"DZNE Clinical Studies: Early Onset Ataxias"},{"key":"B5","unstructured":"Preparing for Therapies in Autosomal Recessive Ataxias (PREPARE) - A Global Consortium"},{"key":"B6","unstructured":"PROSPAX: An Integrated Multimodal Progression Chart in Spastic Ataxias"},{"key":"B7","unstructured":"Ataxia Global Initiatives: ARCA Global"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/S1474-4422(15)00202-1","article-title":"Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study","volume":"14","author":"Jacobi","year":"2015","journal-title":"Lancet Neurol."},{"key":"B9","unstructured":"The European Spinocerebellar Ataxia Type 3 Initiative (ESMI)"},{"key":"B10","unstructured":"Ataxia Global Initiatives: SCA Global"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1212\/WNL.0000000000004311","article-title":"Clinical and genetic characteristics of sporadic adult-onset degenerative ataxia","volume":"89","author":"Giordano","year":"2017","journal-title":"Neurology."},{"key":"B12","unstructured":"Sporadic Degenerative Ataxia With Adult Onset: Natural History Study (SPORTAX)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1002\/humu.22836","article-title":"Innovative genomic collaboration using the GENESIS (GEM. app) platform","volume":"36","author":"Gonzalez","year":"2015","journal-title":"Hum Mutat."},{"key":"B14","unstructured":"GENESIS Software Platform"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1212\/01.WNL.0000156802.15466.79","article-title":"Measuring Friedreich ataxia: interrater reliability of a neurologic rating scale","volume":"64","author":"Subramony","year":"2005","journal-title":"Neurology."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1212\/01.wnl.0000219042.60538.92","article-title":"Scale for the assessment and rating of ataxia: development of a new clinical scale","volume":"66","author":"Schmitz-H\u00fcbsch","year":"2006","journal-title":"Neurology."},{"key":"B17","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1212\/01.wnl.0000325057.33666.72","article-title":"Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms","volume":"71","author":"Schmitz-H\u00fcbsch","year":"2008","journal-title":"Neurology."},{"key":"B18","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol-a new facility for the measurement of health-related quality of life","volume":"16","author":"Group","year":"1990","journal-title":"Health Policy."},{"key":"B19","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e1543","DOI":"10.1212\/WNL.0000000000008313","article-title":"Development and validation of a disease severity index for ataxia of Charlevoix-Saguenay","volume":"93","author":"Gagnon","year":"2019","journal-title":"Neurology."},{"key":"B21","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1212\/WNL.0b013e3181d1a6c9","article-title":"Responsiveness of different rating instruments in spinocerebellar ataxia patients","volume":"74","author":"Schmitz-H\u00fcbsch","year":"2010","journal-title":"Neurology."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7525-4-54","article-title":"Minimal changes in health status questionnaires: distinction between minimally detectable change and minimally important change","volume":"4","author":"de Vet","year":"2006","journal-title":"Health Qual Life Outcom."},{"key":"B23","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1001\/jamaneurol.2017.5121","article-title":"Efficacy of exome-targeted capture sequencing to detect mutations in known cerebellar ataxia genes","volume":"75","author":"Coutelier","year":"2018","journal-title":"JAMA Neurol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e1369","DOI":"10.1212\/WNL.0000000000011528","article-title":"Natural history, phenotypic spectrum, and discriminative features of multisystemic RFC1-disease","volume":"96","author":"Trasch\u00fctz","year":"2021","journal-title":"Neurology."},{"key":"B25","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/ana.25751","article-title":"Clinico-genetic, imaging and molecular delineation of COQ8A-ataxia: a multicenter study of 59 patients","volume":"88","author":"Traschutz","year":"2020","journal-title":"Ann Neurol."},{"key":"B26","article-title":"Natural history of polymerase gamma related ataxia (Submitted)","author":"Bender","year":"2021"},{"key":"B27","doi-asserted-by":"publisher","first-page":"awab071","DOI":"10.1093\/brain\/awab071","article-title":"Biallelic loss-of-function variations in PRDX3 cause cerebellar ataxia","volume":"2021","author":"Rebelo","year":"2021","journal-title":"Brain"},{"key":"B28","unstructured":"European Reference Network - Rare Neurological Diseases (ERN-RND) Registry"},{"key":"B29","unstructured":""},{"key":"B30","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s41431-018-0115-5","article-title":"RD-Connect, NeurOmics and EURenOmics: collaborative European initiative for rare diseases","volume":"26","author":"Lochm\u00fcller","year":"2018","journal-title":"Eur J Hum Genet."},{"key":"B31","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1007\/s12311-012-0421-3","article-title":"Inventory of Non-Ataxia Signs (INAS): validation of a new clinical assessment instrument","volume":"12","author":"Jacobi","year":"2013","journal-title":"Cerebellum."},{"key":"B32","unstructured":"Ataxia Study Group (ASG)"},{"key":"B33","unstructured":""},{"key":"B34","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/mds.26944","article-title":"Overcoming the divide between ataxias and spastic paraplegias: shared phenotypes, genes, and pathways","volume":"32","author":"Synofzik","year":"2017","journal-title":"Mov Disord."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.677551\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T02:41:08Z","timestamp":1624588868000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.677551\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,25]]},"references-count":34,"alternative-id":["10.3389\/fneur.2021.677551"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.677551","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,25]]},"article-number":"677551"}}